middle.news
How Is Genetic Signatures Transforming to Capture New Infectious Disease Markets?
8:40am on Monday 17th of November, 2025 AEDT
•
Healthcare
Read Story
How Is Genetic Signatures Transforming to Capture New Infectious Disease Markets?
8:40am on Monday 17th of November, 2025 AEDT
Key Points
66% revenue growth to $14.4 million in FY25
Leadership changes with new Chair Caroline Waldron and CEO Allison Rossiter
Strategic pivot away from in-house automation to partnerships
First commercial contracts secured in the US market
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE